A-485 ≥98% (HPLC) | Sigma-Aldrich
p300/CBP inhibitor A-485 alleviates acute liver injury by regulating macrophage activation and polarization
Bundesautobahn 485 - Wikipedia
A-485 | SGC
A novel histone acetyltransferase inhibitor A485 improves sensitivity of non-small-cell lung carcinoma cells to TRAIL - ScienceDirect
If You've Wanted a 485-HP Hemi-Powered Chrysler 300, Here It Is
A-485 | SGC
Therapeutic targeting of p300/CBP HAT domain for the treatment of NUT midline carcinoma | Oncogene
Discovery of a Potent and Selective Covalent p300/CBP Inhibitor | ACS Medicinal Chemistry Letters
Promoter-specific changes in initiation, elongation, and homeostasis of histone H3 acetylation during CBP/p300 inhibition | eLife
Discovery of a Potent and Selective Covalent p300/CBP Inhibitor | ACS Medicinal Chemistry Letters
A-485 | p300/CBP Inhibitor | Tocris Bioscience
A-485 potently inhibits p300/CBP in cells (a) Analysis of high content... | Download Scientific Diagram
A novel histone acetyltransferase inhibitor A485 improves sensitivity of non-small-cell lung carcinoma cells to TRAIL - ScienceDirect
p300/CBP inhibitor A-485 inhibits the differentiation of osteoclasts and protects against osteoporotic bone loss - ScienceDirect
A-485 | SGC
A-485 | p300/CBP Inhibitor | MedChemExpress
A-485 | p300/CBP Inhibitor | MedChemExpress
CREBBP/EP300 bromodomains are critical to sustain the GATA1/MYC regulatory axis in proliferation | Epigenetics & Chromatin | Full Text
A-485 | p300/CBP Inhibitor | MedChemExpress
Promoter-specific changes in initiation, elongation, and homeostasis of histone H3 acetylation during CBP/p300 inhibition | eLife
A-485 | SGC
RCSB PDB - 5KJ2: The novel p300/CBP inhibitor A-485 uncovers a unique mechanism of action to target AR in castrate resistant prostate cancer
